IL1B and metabolic dysfunction-associated steatohepatitis: IL-1β is mostly produced by KCs and has pro-inflammatory effects in the development of NASH by inhibiting peroxisome proliferator-activated receptor-α (PPAR-α) and enhancing the TNF-α role in cell death stimulation [93,94].